Shell Asset Management Co. Raises Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST)

Shell Asset Management Co. raised its stake in West Pharmaceutical Services, Inc. (NYSE:WST) by 8.0% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 19,139 shares of the medical instruments supplier’s stock after buying an additional 1,416 shares during the period. Shell Asset Management Co.’s holdings in West Pharmaceutical Services were worth $6,873,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of WST. FMR LLC increased its holdings in West Pharmaceutical Services by 41.3% in the first quarter. FMR LLC now owns 794 shares of the medical instruments supplier’s stock valued at $88,000 after buying an additional 232 shares in the last quarter. The PNC Financial Services Group Inc. increased its holdings in West Pharmaceutical Services by 7.5% in the first quarter. The PNC Financial Services Group Inc. now owns 10,741 shares of the medical instruments supplier’s stock valued at $3,027,000 after buying an additional 749 shares in the last quarter. Sowell Financial Services LLC increased its holdings in West Pharmaceutical Services by 94.8% in the first quarter. Sowell Financial Services LLC now owns 113 shares of the medical instruments supplier’s stock valued at $37,000 after buying an additional 55 shares in the last quarter. Alps Advisors Inc. increased its holdings in West Pharmaceutical Services by 33.0% in the first quarter. Alps Advisors Inc. now owns 1,237 shares of the medical instruments supplier’s stock valued at $349,000 after buying an additional 307 shares in the last quarter. Finally, Alberta Investment Management Corp acquired a new stake in shares of West Pharmaceutical Services in the first quarter valued at approximately $1,183,000. 92.74% of the stock is owned by institutional investors.

Separately, KeyCorp increased their price target on shares of West Pharmaceutical Services from $350.00 to $475.00 and gave the company an “overweight” rating in a research report on Friday, July 30th.

In related news, VP Quintin J. Lai sold 9,672 shares of the firm’s stock in a transaction that occurred on Friday, September 10th. The shares were sold at an average price of $460.76, for a total transaction of $4,456,470.72. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.66% of the stock is currently owned by company insiders.

WST stock opened at $457.11 on Monday. The company’s 50 day simple moving average is $432.69 and its 200-day simple moving average is $364.06. The firm has a market capitalization of $33.82 billion, a PE ratio of 66.83, a P/E/G ratio of 1.96 and a beta of 1.00. West Pharmaceutical Services, Inc. has a 12 month low of $253.85 and a 12 month high of $475.35. The company has a debt-to-equity ratio of 0.12, a current ratio of 3.13 and a quick ratio of 2.39.

West Pharmaceutical Services (NYSE:WST) last released its quarterly earnings results on Thursday, July 29th. The medical instruments supplier reported $2.46 EPS for the quarter, beating the consensus estimate of $1.74 by $0.72. West Pharmaceutical Services had a net margin of 20.58% and a return on equity of 28.58%. The business had revenue of $723.60 million for the quarter, compared to analyst estimates of $665.55 million. As a group, sell-side analysts anticipate that West Pharmaceutical Services, Inc. will post 8.22 earnings per share for the current year.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers.

Featured Story: Learning About the VIX – Volatility Index

Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services, Inc. (NYSE:WST).

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.